Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials

MC Lampi, CA Reinhart-King - Science translational medicine, 2018 - science.org
Tissues stiffen during aging and during the pathological progression of cancer, fibrosis, and
cardiovascular disease. Extracellular matrix stiffness is emerging as a prominent mechanical …

Targeting the receptor for advanced glycation endproducts (RAGE): a medicinal chemistry perspective

S Bongarzone, V Savickas, F Luzi… - Journal of medicinal …, 2017 - ACS Publications
The receptor for advanced glycation endproducts (RAGE) is an ubiquitous, transmembrane,
immunoglobulin-like receptor that exists in multiple isoforms and binds to a diverse range of …

Role of advanced glycation end products in mobility and considerations in possible dietary and nutritional intervention strategies

JH Chen, X Lin, C Bu, X Zhang - Nutrition & metabolism, 2018 - Springer
Advanced glycation end products (AGEs), a group of compounds that are formed by non-
enzymatic reactions between carbonyl groups of reducing sugars and free amino groups of …

Cellular mechanisms underlying obesity-induced arterial stiffness

AR Aroor, G Jia, JR Sowers - American Journal of …, 2018 - journals.physiology.org
Obesity is an emerging pandemic driven by consumption of a diet rich in fat and highly
refined carbohydrates (a Western diet) and a sedentary lifestyle in both children and adults …

Molecular characteristics of RAGE and advances in small-molecule inhibitors

HJ Kim, MS Jeong, SB Jang - International journal of molecular sciences, 2021 - mdpi.com
Receptor for advanced glycation end-products (RAGE) is a member of the immunoglobulin
superfamily. RAGE binds and mediates cellular responses to a range of DAMPs (damage …

The multifunctional roles of flavonoids against the formation of advanced glycation end products (AGEs) and AGEs-induced harmful effects

Q Zhou, KW Cheng, J Xiao, M Wang - Trends in Food Science & …, 2020 - Elsevier
Background Advanced glycation end products (AGEs) play a crucial role in the onset,
progression, and propagation of both macroangiopathy and microangiopathy complications …

Advanced glycation end-products as mediators of the aberrant crosslinking of extracellular matrix in scarred liver tissue

C Lyu, W Kong, Z Liu, S Wang, P Zhao… - Nature biomedical …, 2023 - nature.com
The extracellular matrix of cirrhotic liver tissue is highly crosslinked. Here we show that
advanced glycation end-products (AGEs) mediate crosslinking in liver extracellular matrix …

Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors

H Singh, DK Agrawal - Drug development research, 2022 - Wiley Online Library
Receptor for advanced glycation end products (RAGE) is a 45 kDa transmembrane receptor
of immunoglobulin family that can bind to various endogenous and exogenous ligands and …

Oxidative stress and advanced glycation end products in Hashimoto's thyroiditis

RM Ruggeri, TM Vicchio, M Cristani, R Certo… - Thyroid, 2016 - liebertpub.com
Background: Oxidative stress, which occurs as a result of an imbalance between free-radical
production and antioxidant defense mechanisms, has been implicated in the pathogenesis …

Preventing treatment failures in coronary artery disease: what can we learn from the biology of in-stent restenosis, vein graft failure, and internal thoracic arteries?

C Spadaccio, C Antoniades, A Nenna… - Cardiovascular …, 2020 - academic.oup.com
Coronary artery disease (CAD) remains one of the most important causes of morbidity and
mortality worldwide, and the availability of percutaneous or surgical revascularization …